![Lewis Bender](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lewis Bender
Vorstandsvorsitzender bei
INTENSITY THERAPEUTICS, INC.
Vermögen: 520 430 $ am 31.05.2026
Profil
Lewis H.
Bender is the founder of Intensity Therapeutics, Inc., founded in 2012, where the titles held include Chairman, President & Chief Executive Officer.
Former jobs include Chief Executive Officer & Director at Interleukin Genetics, Inc. from 2011 to 2012, and President, CEO & Chief Technology Officer at Emisphere Technologies, Inc. from 1993 to 2007.
Education history includes graduate studies at the University of Pennsylvania, undergraduate and graduate degrees from the Massachusetts Institute of Technology, and an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2026 | 118’549 ( 4.39% ) | 520 430 $ | 31.05.2026 |
Aktive Positionen von Lewis Bender
| Unternehmen | Position | Beginn |
|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.04.2012 |
Ehemalige bekannte Positionen von Lewis Bender
| Unternehmen | Position | Ende |
|---|---|---|
| INTERLEUKIN GENETICS, INC | Vorstandsvorsitzender | 23.08.2012 |
| EMISPHERE TECHNOLOGIES, INC. | Vorstandsvorsitzender | 01.12.2007 |
Ausbildung von Lewis Bender
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
37
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops personalized health products | Health Technology |
Intensity Therapeutics, Inc.
 Intensity Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops and markets proprietary intratumoral immunotherapy products for cancer treatment | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
